Hennion & Walsh Asset Management, Inc. Procept Bio Robotics Corp Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 9,624 shares of PRCT stock, worth $577,921. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,624
Previous 5,922
62.51%
Holding current value
$577,921
Previous $474,000
63.29%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
294Shares Held
40.1MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$309 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$209 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$105 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$72.5 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$71.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.68B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...